Arcus Biosciences · 1 month ago
Drug Metabolism Pharmacokinetics (DMPK) - ADME Intern
Arcus Biosciences is seeking a highly motivated individual to join their Drug Metabolism and Pharmacokinetics team for a summer internship. This internship is designed to provide undergraduate and graduate students with hands-on experience in pharmaceutical Research & Development, focusing on ADME computational models.
BiopharmaBiotechnologyClinical TrialsHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Gain hands-on experience with ADME computational modeling in a pharmaceutical R&D setting
Integrate ADME computational models into interactive web applications using Streamlit or Shiny library
Collaborate with Research Informatics team to deploy the applications on the server
Other projects as assigned
Qualification
Required
Currently enrolled in a Bachelor's, Master's or PhD program in Computational Chemistry, Data Science, or related field
Proficiency in Python and/or R is required
Strong analytical and problem-solving skills
Preferred
Experience developing interactive applications using Streamlit or Shiny is a plus
Familiarity with basic ADME concepts and computational models is highly desirable
Company
Arcus Biosciences
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
H1B Sponsorship
Arcus Biosciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (15)
2023 (18)
2022 (20)
2021 (15)
2020 (10)
Funding
Current Stage
Public CompanyTotal Funding
$1.52BKey Investors
Hercules CapitalGilead SciencesGoogle Ventures
2025-10-30Post Ipo Equity· $250M
2025-02-18Post Ipo Equity· $150M
2024-08-27Post Ipo Debt· $150M
Recent News
2025-12-18
2025-12-16
Company data provided by crunchbase